The VIOV fund tracks the S&P SmallCap 600 Value Index, a market-cap-weighted benchmark of small-capitalization U.S. companies selected from the S&P SmallCap 600 for value characteristics such as book value, earnings, and sales relative to price. The fund uses a full-replication approach, holding roughly 460–470 stocks, and charges a net expense ratio of 0.10%, making it one of the lowest-cost ways to access this segment of the U.S. equity market. I also checked this using Tickeron’s AI Screener to see how the holdings compare to others in the industry.
Portfolio exposure is notably concentrated in rate- and economy-sensitive areas. Financials are the largest sector weight at roughly 21%, followed by consumer discretionary (about 16–18%) and industrials (around 13%). Information technology, healthcare, real estate, energy, and materials each represent mid-single-digit to low-teens weightings. Top holdings include Molina Healthcare, Match Group, Eastman Chemical, CarMax, Jackson Financial, Paycom Software, SM Energy, Lincoln National, and Conagra Brands — a mix of regional financials, consumer cyclical names, and niche industrial and healthcare companies. Geographically, the fund is overwhelmingly domestic, with roughly 94% of assets in U.S. companies.
This structural positioning means VIOV's future outlook is closely tied to the domestic credit cycle, consumer balance sheets, and small-business confidence. Because small-cap value companies tend to be more domestically oriented and more leveraged than mega-cap peers, the fund is structurally geared to a reaccelerating economy and a steeper, more favorable funding environment.
The macro outlook is central to any small-cap value forecast. Small-cap equities are historically more sensitive to interest rates than large caps because they rely more on floating-rate and shorter-duration debt. A dovish Fed, falling short-term yields, and a steepening yield curve would tend to support bank profitability and ease financing for industrial and consumer cyclical names. Conversely, stubborn inflation or a renewed tightening bias would raise the cost of capital and pressure already-thin small-cap margins.
The sector outlook reinforces this dependence on the domestic economy. Financials should benefit from a healthier net interest margin environment if rates stabilize at more accommodative levels, while industrials and consumer discretionary remain tied to the manufacturing cycle and household spending. The index's relatively light technology weighting — a structural feature of value investing — means VIOV's trajectory may diverge from the mega-cap, AI-driven leadership that has dominated broader market trends. From a valuation standpoint, the S&P 600 trades at a meaningful discount to the S&P 500, historically a supportive backdrop for value and size rotation when economic growth holds up.
Over the long run, VIOV's future outlook is shaped by several durable forces. The profitability screen embedded in the S&P SmallCap 600 methodology excludes many unprofitable small caps, which historically has supported higher quality and lower volatility relative to broader small-cap indexes. This structural quality tilt may matter as investors increasingly favor balance-sheet strength and cash-flow stability over speculative growth.
Demographic and economic trends also play a role. An aging U.S. population and rising demand for healthcare services could support the fund's healthcare names, while reshoring of manufacturing and infrastructure investment could benefit its industrial and materials holdings. The long-term interest-rate cycle is another key variable: a sustained move toward lower, more stable rates would generally favor financials and domestic cyclical businesses, whereas a prolonged high-rate environment could keep pressure on leveraged small-cap issuers. Global investment trends, including a broadening of equity leadership beyond mega-cap technology, could further support value and size factors over the coming cycle.
I often turn to Tickeron's Trend Prediction Engine when evaluating ETFs like this one. The tool provides AI-driven forecasts on potential bullish, bearish, or sideways moves over the next week or month, along with historical context and alerts. It helps me cross-check momentum signals and refine my own views on how rate shifts or sector rotations might play out for holdings in the small-cap value space.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
VIOV broke above its upper Bollinger Band on October 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 38 similar instances where the stock broke above the upper band. In 37 of the 38 cases the stock fell afterwards. This puts the odds of success at 90%.
The Momentum Indicator moved below the 0 level on November 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on VIOV as a result. In 67 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 78%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VIOV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 58 of 63 cases where VIOV's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
VIOV moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for VIOV crossed bullishly above the 50-day moving average on November 03, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 86%.
Following a +0.70% 3-day Advance, the price is estimated to grow further. Considering data from situations where VIOV advanced for three days, in 240 of 289 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
The Aroon Indicator entered an Uptrend today. In 208 of 255 cases where VIOV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 82%.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows